Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3231) 3231
Book Review (595) 595
Publication (158) 158
Book Chapter (18) 18
Magazine Article (12) 12
Conference Proceeding (8) 8
Dissertation (2) 2
Paper (2) 2
Reference (2) 2
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2814) 2814
humans (2592) 2592
homocysteine (1754) 1754
hyperhomocysteinemia (1749) 1749
male (1733) 1733
female (1679) 1679
homocysteine - blood (1391) 1391
middle aged (1232) 1232
risk factors (1121) 1121
adult (1006) 1006
aged (879) 879
hyperhomocysteinemia - complications (863) 863
plasma homocysteine (634) 634
vascular-disease (628) 628
hyperhomocysteinemia - drug therapy (615) 615
hyperhomocysteinemia - blood (573) 573
animals (499) 499
folic acid (489) 489
folate (447) 447
folic acid - therapeutic use (426) 426
cardiovascular-disease (421) 421
folic-acid (416) 416
atherosclerosis (413) 413
peripheral vascular disease (377) 377
risk factor (354) 354
disease (353) 353
folic acid - blood (348) 348
methylenetetrahydrofolate reductase (348) 348
risk-factor (318) 318
oxidative stress (317) 317
risk (315) 315
homocysteine - metabolism (292) 292
vitamin b 12 - blood (281) 281
hyperhomocysteinemia - genetics (277) 277
abridged index medicus (273) 273
urology & nephrology (270) 270
aged, 80 and over (261) 261
folic acid - administration & dosage (261) 261
case-control studies (259) 259
methylenetetrahydrofolate reductase - genetics (257) 257
hyperhomocysteinemia - metabolism (249) 249
cardiovascular disease (248) 248
hyperhomocysteinemia - epidemiology (247) 247
hematology (246) 246
medicine, general & internal (246) 246
cardiac & cardiovascular systems (245) 245
vitamin b (245) 245
hyperhomocysteinemia - etiology (240) 240
nutrition & dietetics (233) 233
adolescent (228) 228
metabolism (228) 228
prospective studies (225) 225
mutation (223) 223
treatment outcome (221) 221
rats (220) 220
dietary supplements (218) 218
prevalence (218) 218
thrombosis (213) 213
stroke (212) 212
hyperhomocysteinemia - physiopathology (208) 208
physiological aspects (206) 206
biomarkers - blood (205) 205
clinical neurology (201) 201
genotype (201) 201
cardiovascular diseases - etiology (200) 200
vitamin b 12 - therapeutic use (199) 199
health aspects (197) 197
myocardial-infarction (194) 194
hyperhomocysteinemia - diagnosis (191) 191
analysis (182) 182
kidney failure, chronic - therapy (181) 181
neurosciences (181) 181
research (178) 178
mice (177) 177
methionine (176) 176
renal dialysis (175) 175
endothelial dysfunction (174) 174
mortality (172) 172
care and treatment (169) 169
plasma (167) 167
endocrinology & metabolism (166) 166
vitamin b complex - therapeutic use (163) 163
hypertension (158) 158
biochemistry & molecular biology (157) 157
cardiovascular diseases (157) 157
cross-sectional studies (152) 152
medicine, research & experimental (148) 148
plasma total homocysteine (147) 147
homocystine (146) 146
kidney failure, chronic - blood (146) 146
vitamin b12 (146) 146
polymorphism, genetic (145) 145
stage renal-disease (144) 144
time factors (143) 143
follow-up studies (142) 142
medicine & public health (142) 142
risk-factors (139) 139
metaanalysis (138) 138
therapy (138) 138
pharmacology & pharmacy (137) 137
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3042) 3042
French (41) 41
Spanish (36) 36
German (30) 30
Polish (25) 25
Italian (20) 20
Russian (17) 17
Chinese (15) 15
Japanese (8) 8
Portuguese (7) 7
Dutch (6) 6
Hungarian (5) 5
Croatian (2) 2
Czech (2) 2
Turkish (2) 2
Icelandic (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American stroke association
by Furie, Karen L and Kasner, Scott E and Adams, Robert J and Albers, Gregory W and Bush, Ruth L and Fagan, Susan C and Halperin, Jonathan L and Johnston, S. Claiborne and Katzan, Irene and Kernan, Walter N and Mitchell, Pamela H and Ovbiagele, Bruce and Palesch, Yuko Y and Sacco, Ralph L and Schwamm, Lee H and Wassertheil-Smoller, Sylvia and Turan, Tanya N and Wentworth, Deidre and Council Cardiovasc Nursing and Interdisciplinary Council Quality and Amer Heart Assoc Stroke Council and Council Clin Cardiology and American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research
Stroke, ISSN 0039-2499, 01/2011, Volume 42, Issue 1, pp. 227 - 276
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of... 
AHA scientific statements | Stroke | Stroke prevention | Transient ischemic attack | Ischemia | ACTIVATED PROTEIN-C | PATENT FORAMEN OVALE | transient ischemic attack | DENSITY-LIPOPROTEIN-CHOLESTEROL | LEFT-VENTRICULAR THROMBI | stroke | CLINICAL NEUROLOGY | AHA Scientific Statements | ischemia | FACTOR-V-LEIDEN | CLINICAL-CARDIOLOGY-SUBCOMMITTEE | SICKLE-CELL-ANEMIA | BODY-MASS INDEX | PERIPHERAL VASCULAR DISEASE | stroke prevention | INTERNAL CAROTID-ARTERY | INDEPENDENT RISK-FACTOR | Recurrence | Thrombophilia - therapy | Ischemic Attack, Transient - therapy | Embolism - therapy | Thrombosis - complications | Humans | Hyperhomocysteinemia - therapy | Male | Thrombophilia - complications | Ischemic Attack, Transient - complications | Atherosclerosis - therapy | Heart Diseases - complications | Cerebral Hemorrhage - therapy | Female | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Platelet Aggregation Inhibitors - adverse effects | Pregnancy Complications, Cardiovascular - therapy | Stroke - prevention & control | Foramen Ovale, Patent - therapy | Embolism - complications | Anemia, Sickle Cell - complications | Risk Factors | Anticoagulants - therapeutic use | Atherosclerosis - complications | Anticoagulants - adverse effects | Evidence-Based Medicine | Pregnancy | Anemia, Sickle Cell - therapy | Stroke - etiology | Heart Diseases - therapy | Foramen Ovale, Patent - complications | Cerebral Hemorrhage - complications | Hyperhomocysteinemia - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial
by House, Andrew A and Eliasziw, Misha and Cattran, Daniel C and Churchill, David N and Oliver, Matthew J and Fine, Adrian and Dresser, George K and Spence, J. David
JAMA, ISSN 0098-7484, 04/2010, Volume 303, Issue 16, pp. 1603 - 1609
CONTEXT Hyperhomocysteinemia is frequently observed in patients with diabetic nephropathy. B-vitamin therapy (folic acid, vitamin B6, and vitamin B12) has been... 
SERUM CREATININE | MORTALITY | HOMOCYSTEINE | MEDICINE, GENERAL & INTERNAL | HYPERHOMOCYSTEINEMIA | MYOCARDIAL-INFARCTION | STROKE PREVENTION | CARDIOVASCULAR EVENTS | FOLIC-ACID | INTERVENTION | VASCULAR-DISEASE | Vitamin B 12 - administration & dosage | Vitamin B Complex - adverse effects | Glomerular Filtration Rate | Kidney - drug effects | Double-Blind Method | Folic Acid - adverse effects | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Vitamin B 12 - adverse effects | Male | Hyperhomocysteinemia - etiology | Folic Acid - administration & dosage | Hyperhomocysteinemia - drug therapy | Vitamin B 6 - administration & dosage | Vitamin B Complex - administration & dosage | Diabetic Nephropathies - complications | Vitamin B 6 - adverse effects | Female | Aged | Kidney - physiopathology | Diabetic neuropathy | Cardiovascular disease | Drug therapy | Vitamin B | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial
by Xu, Xin and Qin, Xianhui and Li, Youbao and Sun, Danhua and Wang, Jun and Liang, Min and Wang, Binyan and Huo, Yong and Hou, Fan Fan and CSPPT and investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT) and for the investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT)
JAMA Internal Medicine, ISSN 2168-6106, 10/2016, Volume 176, Issue 10, pp. 1443 - 1450
IMPORTANCE: The efficacy of folic acid therapy on renal outcomes has not been previously investigated in populations without folic acid fortification.... 
B-VITAMIN THERAPY | POPULATION | MEDICINE, GENERAL & INTERNAL | HYPERHOMOCYSTEINEMIA | METAANALYSIS | CARDIOVASCULAR-DISEASE | DIABETIC-NEPHROPATHY | PEOPLE | OUTCOMES | ASSOCIATION | BLOOD-PRESSURE | Folic Acid - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Vitamin B Complex - therapeutic use | Humans | Kidney Failure, Chronic - drug therapy | Middle Aged | Homocysteine - blood | Hypertension - drug therapy | Male | Enalapril - therapeutic use | Disease Progression | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | China | Folic Acid - blood | Female | Aged | Drug Combinations | Care and treatment | Usage | Adults | Chronic kidney failure | Health aspects | Folic acid | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Homocysteine-lowering therapy and stroke risk, severity, and disability: Additional findings from the HOPE 2 trial
by Saposnik, Gustavo and Ray, Joel G and Sheridan, Patrick and McQueen, Matthew and Lonn, Eva and HOPE 2 Investigators and Heart Outcomes Prevention Evaluation 2 Investigators and the HOPE 2 Investigators
Stroke, ISSN 0039-2499, 04/2009, Volume 40, Issue 4, pp. 1365 - 1372
Background and Purpose-Elevated total homocysteine is associated with a higher risk of cerebrovascular disease. It is not known whether lowering homocysteine... 
Stroke prevention | Randomized clinical trial | Secondary stroke | Cardiovascular disease | Primary stroke | Homocysteine | Vitamin B12 | Folate | Folic acid | homocysteine | primary stroke | cardiovascular disease | METAANALYSIS | EFFICACY | VITAMIN INTERVENTION | PREVENTION | randomized clinical trial | secondary stroke | FOLIC-ACID SUPPLEMENTATION | CLINICAL NEUROLOGY | folate | PERIPHERAL VASCULAR DISEASE | vitamin B12 | folic acid | stroke prevention | Disability Evaluation | Hyperhomocysteinemia - epidemiology | Severity of Illness Index | Vitamin B 12 - administration & dosage | Hyperhomocysteinemia - blood | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Homocysteine - blood | Male | Folic Acid - administration & dosage | Stroke - physiopathology | Hyperhomocysteinemia - drug therapy | Vitamin B 6 - administration & dosage | Vitamin B Complex - administration & dosage | Female | Stroke - epidemiology | Aged | Vitamins - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Homocysteine-lowering therapy and risk for venous thromboembolism: A randomized trial
by Ray, Joel G and Kearon, Clive and Yi, Qilong and Sheridan, Patrick and Lonn, Eva and Heart Outcomes Prevention and Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators and for the Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators
Annals of Internal Medicine, ISSN 0003-4819, 06/2007, Volume 146, Issue 11, pp. 761 - 767
Background: Elevated total homocysteine levels are associated with a higher risk for venous thromboembolism. Whether decreasing homocysteine levels with... 
HEART | MEDICINE, GENERAL & INTERNAL | HYPERHOMOCYSTEINEMIA | THROMBOSIS | DISEASE | PREVENTION | HYPERHOMOCYST(E)INEMIA | B-VITAMINS | FOLIC-ACID | Pulmonary Embolism - prevention & control | Folic Acid - therapeutic use | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | Pulmonary Embolism - epidemiology | Vitamin B 12 - therapeutic use | Hyperhomocysteinemia - drug therapy | Incidence | Venous Thrombosis - epidemiology | Vitamin B 6 - therapeutic use | Female | Venous Thrombosis - prevention & control | Aged | Thromboembolism | Thrombophlebitis | Homocysteine | Health aspects | Risk factors | Folic acid | Vitamins | Clinical trials | Cardiovascular disease | Vitamin B | Blood clots | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Folate Therapy and In-Stent Restenosis after Coronary Stenting
by Lange, Helmut and Suryapranata, Harry and De Luca, Giuseppe and Börner, Caspar and Dille, Joep and Kallmayer, Klaus and Pasalary, M. Noor and Scherer, Eberhard and Dambrink, Jan-Henk E
The New England Journal of Medicine, ISSN 0028-4793, 06/2004, Volume 350, Issue 26, pp. 2673 - 2681
Some studies have shown that the use of folate supplementation to lower plasma homocysteine levels reduces the rate of restenosis in patients who have... 
MEDICINE, GENERAL & INTERNAL | HYPERHOMOCYSTEINEMIA | ANGIOPLASTY | RISK-FACTOR | INTIMAL HYPERPLASIA | RAT CAROTID ARTERIES | SMOOTH-MUSCLE-CELLS | ISCHEMIC-HEART-DISEASE | PLASMA HOMOCYSTEINE | VASCULAR-DISEASE | TISSUE FACTOR | Folic Acid - therapeutic use | Folic Acid - adverse effects | Humans | Middle Aged | Vitamin B 12 - adverse effects | Male | Vitamin B 12 - therapeutic use | Coronary Disease - complications | Treatment Failure | Female | Drug Therapy, Combination | Stents | Coronary Vessels - pathology | Double-Blind Method | Risk Factors | Homocysteine - blood | Coronary Restenosis - prevention & control | Coronary Restenosis - chemically induced | Hyperhomocysteinemia - drug therapy | Coronary Angiography | Coronary Disease - pathology | Vitamin B 6 - adverse effects | Vitamin B 6 - therapeutic use | Coronary Disease - therapy | Aged | Hyperhomocysteinemia - complications | Care and treatment | Vitamin therapy | Research | Angioplasty | Coronary stenosis | Cardiovascular disease | Medical imaging | Homocysteine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients A Post Hoc Analysis of the Renal Substudy of CSPPT (China Stroke Primary Prevention Trial)
by Li, YB and Liang, M and Wang, GB and Wang, BY and He, ML and Tang, GF and Yin, DL and Xu, X and Huo, Y and Cui, YM and Hou, FF and Qin, XH
HYPERTENSION, ISSN 0194-911X, 08/2017, Volume 70, Issue 2, pp. 300 - 300
We aimed to test the hypothesis that treatment with enalapril and folic acid is more effective in preventing new-onset proteinuria than enalapril alone among... 
HOMOCYSTEINE | HYPERHOMOCYSTEINEMIA | ALBUMINURIA | enalapril | proteinuria | RENOPROTECTION | diabetes mellitus | DIABETIC-NEPHROPATHY | PREVALENCE | PERIPHERAL VASCULAR DISEASE | folic acid | CHRONIC KIDNEY-DISEASE | hypertension | Folic Acid - adverse effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Drug Monitoring - methods | Folic Acid - administration & dosage | Enalapril - adverse effects | Vitamin B Complex - administration & dosage | Kidney Function Tests | Proteinuria - prevention & control | Drug Interactions | China | Female | Proteinuria - diagnosis | Enalapril - administration & dosage | Hypertension - diagnosis | Proteinuria - etiology | Vitamin B Complex - adverse effects | Double-Blind Method | Mortality | Treatment Outcome | Urinalysis - methods | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Proteinuria - physiopathology | Drug Therapy, Combination - methods | Hypertension - complications | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Efficacy of Folic Acid Therapy in Patients with Hyperhomocysteinemia
by Tian, Huizi and Tian, Dandan and Zhang, Chengda and Wang, Wenhua and Wang, Lianke and Ge, Mengying and Hou, Quanliang and Zhang, Weidong
Journal of the American College of Nutrition, ISSN 0731-5724, 10/2017, Volume 36, Issue 7, pp. 528 - 532
Background: Increased plasma homocysteine (Hcy) levels are a risk factor for stroke and can be reduced with folic acid therapy. Therefore, it is extremely... 
hyperhomocysteinemia | effective rate | baseline level | compliance | Folic acid | CONTROLLED-TRIAL | THROMBOSIS | PLASMA HOMOCYSTEINE CONCENTRATIONS | HUMANS | MAJOR DETERMINANTS | SUPPLEMENTATION | NUTRITION & DIETETICS | VITAMINS | FOLATE | FORTIFICATION | Hyperhomocysteinemia - blood | Folic Acid - pharmacology | Folic Acid - therapeutic use | Prospective Studies | Vitamin B Complex - therapeutic use | Humans | Middle Aged | Risk Factors | Homocysteine - blood | Male | Treatment Outcome | Vitamin B Complex - pharmacology | Hyperhomocysteinemia - drug therapy | Female | Aged | Dietary Supplements | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
by Majtan, Tomas and Jones, Wendell and Krijt, Jakub and Park, Insun and Kruger, Warren D and Kožich, Viktor and Bassnett, Steven and Bublil, Erez M and Kraus, Jan P
Molecular Therapy, ISSN 1525-0016, 03/2018, Volume 26, Issue 3, pp. 834 - 844
Classical homocystinuria (HCU) is the most common inherited disorder of sulfur amino acid metabolism caused by deficiency in cystathionine beta-synthase (CBS)... 
homocysteine | PEGylation | eye defect | alopecia | preclinical studies | metabolomics | bone density | enzyme replacement | cystathionine beta-synthase | inborn error of metabolism | CILIARY ZONULE | MEDICINE, RESEARCH & EXPERIMENTAL | HOMOCYSTEINE | HYPERHOMOCYSTEINEMIA | LIPID-METABOLISM | CYSTATHIONINE BETA-SYNTHASE | CYSTEINE | DEFICIENT MICE | OSTEOPOROSIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MOUSE MODEL | GENETICS & HEREDITY | EXPERIENCE | Liver | Amino acids | Proteins | Glucose metabolism | Genotype & phenotype | Osteoporosis | Homocystinuria | Metabolites | Polyethylene glycol | Lipid metabolism | Cystathionine b-synthase | Sulfur | Enzymes | Phenotypes | Liver diseases | Statistical analysis | Kidneys | Baldness | Methionine | Grants | Metabolism | Bone mass | Alopecia | Biomarkers | Mutation | Homocysteine | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia
by Utpal Sen and Pushpakumar B. Sathnur and Sourav Kundu and Srikanth Givvimani and Denise M. Coley and Paras K. Mishra and Natia Qipshidze and Neetu Tyagi and Naira Metreveli and Suresh C. Tyagi
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 07/2012, Volume 303, Issue 1, pp. 41 - 51
Hydrogen sulfide (H2S) has recently been identified as a regulator of various physiological events, including vasodilation, angiogenesis, antiapoptotic, and... 
Hydrogen sulfide | Cystathionine γ-lyase | Cystathionine β-synthase | 3-mercaptopyruvate sulfurtransferase | Mitophagy | homocysteine | cystathionine gamma-lyase | OXIDATIVE STRESS | PHYSIOLOGY | ENDOTHELIAL DYSFUNCTION | DIABETIC-NEPHROPATHY | ENDOPLASMIC-RETICULUM STRESS | SMOOTH-MUSCLE-CELL | HYDROGEN-SULFIDE | CELL BIOLOGY | MATRIX METALLOPROTEINASES | mitophagy | hydrogen sulfide | EXTRACELLULAR-MATRIX | cystathionine beta-synthase | TIMP-1 EXPRESSION | Hydrogen Sulfide - metabolism | Genetic Therapy | Vascular Endothelial Growth Factor A - biosynthesis | Reactive Oxygen Species - metabolism | Hyperhomocysteinemia - therapy | Hyperhomocysteinemia - metabolism | Cystathionine gamma-Lyase - metabolism | Homocysteine - metabolism | Hypertension, Renovascular - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Forkhead Transcription Factors - metabolism | Renal Artery - metabolism | Cystathionine gamma-Lyase - genetics | Cystathionine beta-Synthase - genetics | Proto-Oncogene Proteins c-akt - metabolism | Organ Culture Techniques | Endostatins - biosynthesis | Mice, Inbred C57BL | Cells, Cultured | Sulfurtransferases - genetics | Hypertension, Renovascular - therapy | Cystathionine beta-Synthase - metabolism | Matrix Metalloproteinase 13 - metabolism | Animals | Hyperhomocysteinemia - genetics | Mice | Forkhead Box Protein O3 | Platelet Endothelial Cell Adhesion Molecule-1 - biosynthesis | Vascular System Injuries | Sulfurtransferases - metabolism | Index Medicus | cystathionine γ-lyase | cystathionine β-synthase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy
by Chambers, John C and McGregor, Andrew and Jean-Marie, Jeff and Obeid, Omar A and Kooner, Jaspal S
Circulation, ISSN 0009-7322, 03/1999, Volume 99, Issue 9, pp. 1156 - 1160
Background-Hyperhomocysteinemia is a major and independent risk factor for vascular disease. The mechanisms by which homocysteine promotes atherosclerosis are... 
Antoxidants | Arteriosclerosis | Nitric oxide | Blood flow | Endothelium | endothelium | nitric oxide | CARDIAC & CARDIOVASCULAR SYSTEMS | INDUCED ARTERIOSCLEROSIS | RISK FACTOR | INJURY | HUMANS | HYPERHOMOCYST(E)INEMIA | arteriosclerosis | ARTERIES | antoxidants | DISEASE | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | blood flow | PLASMA HOMOCYSTEINE | DILATATION | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease
by Shankle, William R and Hara, Junko and Barrentine, Lori W and Curole, Melanie V
Journal of Alzheimer's Disease, ISSN 1387-2877, 2016, Volume 54, Issue 3, pp. 1073 - 1084
We examined whether using a medical food therapy for hyperhomocysteinemia (HHcy) in patients with Alzheimer's disease (AD) or cognitive impairment due to... 
white matter | folate | volumetrics | B12 | hippocampus | brain atrophy | circadian rhythm | dementia | cognitive impairment | vascular | HOMOCYSTEINE | COGNITIVE PERFORMANCE | RANDOMIZED CONTROLLED-TRIAL | FOLIC-ACID | NEUROSCIENCES | SUPPLEMENTATION | N-ACETYL CYSTEINE | B-VITAMIN TREATMENT | DOUBLE-BLIND | Cerebrovascular Disorders - diet therapy | Tetrahydrofolates - administration & dosage | Vitamin B 12 - administration & dosage | Humans | Middle Aged | Vitamin B 12 - analogs & derivatives | Male | Cerebral Cortex - diagnostic imaging | Vitamin B Complex - administration & dosage | Atrophy | Hyperhomocysteinemia - diagnostic imaging | White Matter - diagnostic imaging | Alzheimer Disease - diet therapy | Cerebrovascular Disorders - diagnostic imaging | Aged, 80 and over | Female | Aged | Hyperhomocysteinemia - diet therapy | Alzheimer Disease - diagnostic imaging | Acetylcysteine - administration & dosage | Dietary Supplements | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Efficacy of chelation therapy to remove aluminium intoxication
by Fulgenzi, Alessandro and De Giuseppe, Rachele and Bamonti, Fabrizia and Vietti, Daniele and Ferrero, Maria Elena
Journal of Inorganic Biochemistry, ISSN 0162-0134, 11/2015, Volume 152, pp. 214 - 218
There is a distinct correlation between aluminium (Al) intoxication and neurodegenerative diseases (ND). We demonstrated how patients affected by ND showing Al... 
Chelation therapy | Aluminium | Intoxication | CELLS | OXIDATIVE STRESS | HYPERHOMOCYSTEINEMIA | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROTOXICITY | CHEMISTRY, INORGANIC & NUCLEAR | RISK-FACTOR | MITOCHONDRIAL DYSFUNCTION | EXPOSURE | Aluminum - blood | Chelation Therapy - adverse effects | Aluminum - urine | Humans | Middle Aged | Male | Sulfates - adverse effects | Amino Acids - adverse effects | Amino Acids - therapeutic use | Neurotoxicity Syndromes - drug therapy | Neurotoxicity Syndromes - etiology | Sulfates - therapeutic use | Minerals - therapeutic use | Adolescent | Minerals - adverse effects | Aluminum - poisoning | Enzymes - adverse effects | Adult | Female | Aged | Enzymes - therapeutic use | Antioxidants | Folic acid | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women
by Chakraborty, Pratip and Banerjee, Sayani and Saha, Piyali and Nandi, Shyam Sundar and Sharma, Sunita and Goswami, Sourendra K and Chakravarty, Baidyanath and Kabir, Syed N
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, pp. e74155 - e74155
The management of recurrent pregnancy loss (RPL) still remains a great challenge, and women with polycystic ovarian syndrome (PCOS) are at a greater risk for... 
POLYCYSTIC-OVARY-SYNDROME | CONTROLLED-TRIAL | PLUS HEPARIN | INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | THROMBOPHILIA | 1ST TRIMESTER | COMPLICATIONS | PREGNANCY LOSS | PLASMA HOMOCYSTEINE | ANTIPHOSPHOLIPID SYNDROME | Abortion, Habitual - pathology | Hyperhomocysteinemia - pathology | Prospective Studies | Obesity - drug therapy | Obesity - complications | Humans | Live Birth | Risk Factors | Insulin Resistance | Anticoagulants - therapeutic use | Treatment Outcome | Heparin, Low-Molecular-Weight - therapeutic use | Hyperhomocysteinemia - drug therapy | Obesity - pathology | Pregnancy | Polycystic Ovary Syndrome - complications | Polycystic Ovary Syndrome - drug therapy | Abortion, Habitual - drug therapy | Adult | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Polycystic Ovary Syndrome - pathology | Hyperhomocysteinemia - complications | Prevention | Obesity | Care and treatment | Aspirin | Stein-Leventhal syndrome | Analysis | Insulin resistance | Heparin | Drug therapy, Combination | Miscarriage | Reproductive health | Therapy | Pregnancy complications | Biology | Abortion | Molecular weight | Body mass index | Salvage | Predictive control | Anticoagulants | Subpopulations | Polycystic ovary syndrome | Spontaneous abortion | Regression analysis | Insulin | Thrombosis | Medicine | Womens health | Infertility | Health risk assessment | Homocysteine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights